telmisartan has been researched along with Dementia Praecox in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kar, SK; Srivastava, A | 1 |
| Fan, X; Freudenreich, O; Goff, DC; Henderson, DC; Jarskog, LF; Natarajan, R; Shukair, N; Song, X; Zhao, M | 1 |
| Copeland, P; Fan, X; Freudenreich, O; Goff, DC; Harrington, A; Henderson, DC; Nawras, S | 1 |
| Fan, X; Oh, SJ | 1 |
| Tsutsumi, E; Yamaguchi, K | 1 |
| Kazawa, T; Kuroki, N; Kuwabara, M; Maruki, T; Odagaki, Y; Toyoshima, R; Yamashita, H; Yoda, H | 1 |
| Fernández-Fernández, FJ | 1 |
| Maruki, T; Toyoshima, R; Yamashita, H; Yoda, H | 1 |
1 review(s) available for telmisartan and Dementia Praecox
| Article | Year |
|---|---|
The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Cytokines; Humans; Neurotransmitter Agents; Renin-Angiotensin System; Schizophrenia; Telmisartan | 2019 |
2 trial(s) available for telmisartan and Dementia Praecox
| Article | Year |
|---|---|
The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antipsychotic Agents; Benzimidazoles; Benzoates; Benzodiazepines; Clozapine; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Telmisartan | 2017 |
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial.
Topics: Adult; Antipsychotic Agents; Body Composition; Body Mass Index; Body Weight; Clozapine; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Insulin; Male; Middle Aged; Olanzapine; Schizophrenia; Telmisartan; Treatment Outcome; Triglycerides | 2019 |
5 other study(ies) available for telmisartan and Dementia Praecox
| Article | Year |
|---|---|
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; GABA Modulators; Humans; Hydrochlorothiazide; Lorazepam; Male; Middle Aged; Schizophrenia; Telmisartan; Time | 2017 |
The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antipsychotic Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Risperidone; Schizophrenia; Telmisartan; Tetrazoles | 2010 |
Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine.
Topics: Angiotensin II Type 1 Receptor Blockers; Antipsychotic Agents; Benzimidazoles; Benzoates; Benzodiazepines; Female; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Olanzapine; Receptor, Angiotensin, Type 1; Schizophrenia; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
Telmisartan and obesity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Humans; Obesity; PPAR delta; Risperidone; Schizophrenia; Telmisartan; Weight Loss | 2010 |
Telmisartan, an angiotensin II type-1 receptor blocker, improved insulin resistance in a schizophrenic patient treated with olanzapine: a case report.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antipsychotic Agents; Benzimidazoles; Benzoates; Benzodiazepines; Female; Humans; Insulin Resistance; Olanzapine; Schizophrenia; Telmisartan | 2008 |